Danrui Cui

896 citations

27 papers · 679 · h-index 14

Impact in

Oncology top 10%
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
Molecular Biology
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- RNA modifications and cancer
- PI3K/AKT/mTOR signaling in cancer

Papers in

Molecular Biology 24
- Ubiquitin and proteasome pathways 16
- PI3K/AKT/mTOR signaling in cancer 5
- Protein Degradation and Inhibitors 4
- RNA modifications and cancer 3
Oncology 16
- Cancer-related Molecular Pathways 12
- Peptidase Inhibition and Analysis 3

Co-authors: Yongchao Zhao (24 shared papers)Xiufang Xiong (23 shared papers)Xiaoyu Chen (4 shared papers)Shanshan Gu (1 shared paper)Jianfeng Shu (6 shared papers)Yanli Bi (6 shared papers)Yi Sun (7 shared papers)Xiao-Qing Dai (4 shared papers)
Journals: Cell Death and Differentiation (3 papers)Cancer Letters (2 papers)Advanced Science (2 papers)Cell Death and Disease (2 papers)The FASEB Journal (1 paper)
Partner nations: China Madagascar United States

In The Last Decade

Danrui Cui

24 papers receiving 671 citations

Peers

Countries citing papers authored by Danrui Cui

Since Specialization

Citations

This map shows the geographic impact of Danrui Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danrui Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danrui Cui more than expected).

Fields of papers citing papers by Danrui Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danrui Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danrui Cui. The network helps show where Danrui Cui may publish in the future.

Co-authors

The 25 scholars most cited alongside Danrui Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Danrui Cui Line = papers co-authored together Danrui Cui links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	PROTACs: An Emerging Targeting Technique for Protein Degradation in Drug Discovery BioEssays ·Shanshan Gu, Danrui Cui, Xiaoyu Chen, Xiufang Xiong, Yongchao Zhao	2018	188
2	FBXW7 Confers Radiation Survival by Targeting p53 for Degradation Cell Reports ·Danrui Cui, Xiufang Xiong, Jianfeng Shu, Xiao-Qing Dai, Yi Sun, Yongchao Zhao	2020	67
3	The Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses Frontiers in Cell and Developmental Biology ·Danrui Cui, Ruirui Qu, Dian Liu, Xiufang Xiong, Tingbo Liang, Yongchao Zhao	2021	60
4	Cullin-RING ligases in regulation of autophagy Cell Division ·Danrui Cui, Xiufang Xiong, Yongchao Zhao	2016	55
5	The characteristics and roles of β‐TrCP1/2 in carcinogenesis FEBS Journal ·Yanli Bi, Danrui Cui, Xiufang Xiong, Yongchao Zhao	2020	47
6	The cross talk of two family members of β-TrCP in the regulation of cell autophagy and growth Cell Death and Differentiation ·Danrui Cui, Xiao-Qing Dai, Jianfeng Shu, Ying Ma, Dongping Wei, Xiufang Xiong, Yongchao Zhao	2019	39
7	DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals Oncogene ·Xiaoyu Chen, Xiufang Xiong, Danrui Cui, Fei Yang, Dongping Wei, Haomin Li, Jianfeng Shu, Yanli Bi, Xiao-Qing Dai, Longyuan Gong, Yi Sun, Yongchao Zhao	2019	36
8	The TRAF2-p62 axis promotes proliferation and survival of liver cancer by activating mTORC1 pathway Cell Death and Differentiation ·Xue Liang, Jiping Yao, Danrui Cui, Weiyang Zheng, Yanning Liu, Guohua Lou, Bingjue Ye, Liyan Shui, Yi Sun, Yongchao Zhao, Min Zheng	2023	24
9	SCFβ‐TrCP ubiquitinates CHK1 in an AMPK‐dependent manner in response to glucose deprivation Molecular Oncology ·Ying Ma, Danrui Cui, Xiufang Xiong, Hiroyuki Inuzuka, Wenyi Wei, Yi Sun, Brian J. North, Yongchao Zhao	2018	24
10	Autophagy regulates apoptosis by targeting NOXA for degradation Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Jingchao Wang, Danrui Cui, Shanshan Gu, Xiaoyu Chen, Yanli Bi, Xiufang Xiong, Yongchao Zhao	2018	23
11	AKT inhibitor MK-2206 sensitizes breast cancer cells to MLN4924, a first-in-class NEDD8-activating enzyme (NAE) inhibitor Cell Cycle ·Xiaoyu Chen, Danrui Cui, Yanli Bi, Jianfeng Shu, Xiufang Xiong, Yongchao Zhao	2018	20
12	DEPTOR is a direct p53 target that suppresses cell growth and chemosensitivity Cell Death and Disease ·Danrui Cui, Xiao-Qing Dai, Longyuan Gong, Xiaoyu Chen, Linchen Wang, Xiufang Xiong, Yongchao Zhao	2020	16
13	FBXW7 inactivation induces cellular senescence via accumulation of p53 Cell Death and Disease ·Longyuan Gong, Danrui Cui, Dian Liu, Xiao Z. Shen, Hui Pan, Xiufang Xiong, Yongchao Zhao	2022	15
14	SCFβ-TrCP-mediated degradation of TOP2β promotes cancer cell survival in response to chemotherapeutic drugs targeting topoisomerase II Oncogenesis ·Jianfeng Shu, Danrui Cui, Ying Ma, Xiufang Xiong, Yi Sun, Yongchao Zhao	2020	15
15	DEPTOR inhibits lung tumorigenesis by inactivating the EGFR-mTOR signals Cancer Letters ·Longyuan Gong, Jianfeng Shu, Xiaoyu Chen, Hui Pan, Guoan Chen, Yanli Bi, Danrui Cui, Xufan Li, Dian Liu, Linchen Wang, Yue Wang, Pengyuan Liu, Xiufang Xiong, Yongchao Zhao	2021	13
16	Neddylation modification of ribosomal protein RPS27L or RPS27 by MDM2 or NEDP1 regulates cancer cell survival The FASEB Journal ·Xiufang Xiong, Danrui Cui, Yanli Bi, Yi Sun, Yongchao Zhao	2020	12
17	Targeting Cullin-RING Ubiquitin Ligases and the Applications in PROTACs Advances in experimental medicine and biology ·Longyuan Gong, Danrui Cui, Xiufang Xiong, Yongchao Zhao	2020	10
18	P90 ribosomal S6 kinase confers cancer cell survival by mediating checkpoint kinase 1 degradation in response to glucose stress Cancer Science ·Ying Ma, Danrui Cui, Linchen Wang, Yue Wang, Fei Yang, Hui Pan, Longyuan Gong, Minrun Zhang, Xiufang Xiong, Yongchao Zhao	2021	6
19	The FBXW7‐RPAP2 Axis Controls the Growth of Hepatocellular Carcinoma Cells and Determines the Fate of Liver Cell Differentiation Advanced Science ·Danrui Cui, Shengpeng Shao, Ruirui Qu, Xiaoyu Chen, Shanghong Jiang, Linchen Wang, Longyuan Gong, Tianqi Li, Danyi Zhai, Wenfeng Song, Penghong Song, Yi Sun, Tingbo Liang, Xiufang Xiong, Yongchao Zhao	2025	3
20	The regulatory subunit MoB56 of PP2A phosphatase regulates pathogenicity, growth and development in a protein complex with the atypical catalytic subunit Ppg1 in the rice blast fungus Magnaporthe oryzae Phytopathology Research ·Rui-Jin Wang, Danrui Cui, Rui Zhao, Yujie Jin, Wenhui Zeng, Ye Yang, Linlu Qi, Lihui Xiang, You‐Liang Peng	2023	2

About Danrui Cui

Danrui Cui is a scholar working on Molecular Biology, Oncology, Epidemiology, Cancer Research and Cell Biology, having authored 27 papers that have together received 679 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (16 papers), Cancer-related Molecular Pathways (12 papers), Autophagy in Disease and Therapy (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Protein Degradation and Inhibitors (4 papers), Peptidase Inhibition and Analysis (3 papers), RNA modifications and cancer (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Oncology (212 citations), Molecular Biology (548 citations), Cancer Research (83 citations), Hematology (54 citations) and Epidemiology (105 citations). Danrui Cui has collaborated with scholars based in China, Madagascar and United States. Frequent co-authors include Yongchao Zhao, Xiufang Xiong, Xiaoyu Chen, Shanshan Gu, Jianfeng Shu, Yanli Bi, Yi Sun, Xiao-Qing Dai, Ying Ma and Dian Liu. Their work appears in journals such as Cell Death and Differentiation, Cancer Letters, Advanced Science, Cell Death and Disease and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Danrui Cui

Impact in

Papers in i

In The Last Decade

Danrui Cui

Peers

Countries citing papers authored by Danrui Cui

Fields of papers citing papers by Danrui Cui

All Works

About Danrui Cui

Explore authors with similar magnitude of impact

Papers in